Replies to post #369346 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Well, the vaccine market is much larger.

Remdesivir does $2B-3B/year. A partner would get 80% so $400M-600M/year or $100M-150M/quarter for IPIX. That would still fund many concurrent trials without a sweat. Not to mention the stock price would be well over $10/share.

Go IPIX!